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ABSTRACT 25 
Sympatho-excitation is a characteristic of cardiovascular disease including heart 26 
failure (HF).  The paraventricular nucleus of the hypothalamus (PVN) is an important 27 
site for central integration of sympathetic outflow.  Atrial volume receptors (AVRs) in 28 
the wall of the right atrium transduce cardiovascular variables (pressure/volume) 29 
into an input that is integrated centrally, in for example, the PVN.  Descriptions of 30 
the location and structure of the AVRs as well as the molecular mechanism initiating 31 
transduction remain scarce, nevertheless preautonomic neurons of the PVN have 32 
been consistently identified as making a significant contribution to the sympatho-33 
excitation evident in HF.  Furthermore, excitatory and inhibitory interactions within 34 
the PVN determine sympathetic tone.  A nitric oxide dependent GABAergic  35 
inhibition sets the prevailing sympathetic output from the PVN, which in HF becomes 36 
dysregulated.  Inflammation and oxidative stress have been recognised as possible 37 
triggers to the disinhibition.  The actions of proinflammatory cytokines and reactive 38 
oxygen species in relation to the signalling pathways, which are important in 39 
generating sympathetic tone are discussed, as well as the contribution these might 40 
make to abnormal control of the sympathetic nervous system in cardiovascular 41 
disease.  42 
 43 
Key words: atrial volume reflex arc, atrial volume receptors, sympathetic efferent 44 
output, paraventricular nucleus of the hypothalamus, heart failure.  45 
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1. INTRODUCTION 46 
Cardiovascular regulation is a key component in mammalian survival.  The process of 47 
maintaining adequate organ perfusion in the face of a continually varying metabolic 48 
demand requires integration of a multitude of “signals” to produce a co-ordinated 49 
cardiovascular output.  This is achieved in part by defined reflex responses that react 50 
to disturbances not only in cardiovascular variables, (pressure, volume) but also to 51 
neuroendocrine stimuli.  Specific neuronal networks within the autonomic control 52 
centres in the hypothalamus and medulla produce an adaptive neurohumoral 53 
response to match the organ perfusion demand.  54 
A key reflex regulating cardiovascular function, in particular blood volume 55 
homeostasis, involves the atrial volume receptors (AVR’s), the paraventricular 56 
nucleus of the hypothalamus (PVN) and the autonomic nervous system.  This reflex 57 
underpins normal water and electrolyte regulation, but in cardiovascular disease 58 
especially heart failure (HF) following a myocardial infarction (MI), this reflex 59 
becomes dysfunctional.  In this review we intend to highlight the recent advances in 60 
our understanding of this reflex and its possible role in the pathophysiology of 61 
cardiovascular disease. 62 
 63 
2. Central Control of Sympathetic Efferents 64 
Control of the autonomic nervous system, in particular the sympathetic nervous 65 
system, originates in several areas of the brain including the nucleus tractus solitarii 66 
(NTS), rostral ventrolateral medulla (RVLM) and the PVN (Guyenet, 2006).  The role 67 
of the PVN in cardiovascular homeostasis and involvement in the generation of 68 
abnormal sympathetic outflow in HF has been extensively reviewed (Pyner, 2009, 69 
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2014).  There is general agreement that the PVN receives visceral cardiovascular 70 
signals from the NTS and then using its direct and indirect projections influences 71 
sympathetic outflow through the sympathetic preganglionc neurons in the spinal 72 
cord (Figure 1). A balance between the excitatory actions of glutamate and 73 
angiotensin II (ANGII) and the inhibitory actions of nitric oxide (NO) and gamma-74 
aminobutyric acid (GABA) determine output from the preautonomic neurons of the 75 
PVN.  At rest the prevailing state of these neurons is tonic inactivity determined by 76 
an NO mediated GABAergic inhibition.  Nitric oxide in the brain is generated by the 77 
enzymes of the nitric oxide synthase (NOS) family.  In HF the preautonomic neurons 78 
become disinhibited leading to increased sympathetic activity.  The fundamental 79 
mechanism underpinning sympatho-excitation in HF involves loss of NOS signalling 80 
(Biancardi et al., 2010; Wang et al., 2014).  Inflammation and oxidative stress are 81 
being touted as novel mechanisms by which the loss of NOS signalling may occur 82 
leading to sympatho-excitation. 83 
Again, the role neurotransmitters play in abnormal sympatho-excitaion in HF has 84 
been extensively reviewed (Pyner, 2009, 2014).  To focus on NO, within the brain, all 85 
three isoforms of NOS, inducible (iNOS), endothelial (eNOS) and neuronal (nNOS) 86 
contribute to the production of NO (Stern, 2004).  In healthy animals, PVN NO acts to 87 
suppress sympathetic activity by inhibiting the excitatory neurotransmitter 88 
glutamate receptor (NMDA) and by facilitating tonic GABAergic inhibition.  89 
Glutamatergic activity also leads to NO production by nNOS creating a negative 90 
feedback loop.  Nitric oxide release is tightly controlled to ensure specificity and 91 
avoid toxicity (Alderton et al., 2001) and this mechanism appears to be dysfunctional 92 
in HF.  The signalling proteins CAPON (carboxy-terminal PDZ ligand-PSD95/Discs 93 
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large/zona occludens-1 of nNOS) and PIN (protein inhibitor of nNOS) regulate NO 94 
generation.  Activation of the NMDA receptor leads to Ca2+ entry into the cytoplasm 95 
of the preautonomic neuron.  The enzyme nNOS forms a complex with the 96 
polysynaptic density protein PSD95 domain of the NMDA receptor that places the 97 
nNOS enzyme in close proximity to the entering Ca2+ promoting Ca2+-calmodulin-98 
induced activation of nNOS and thus production of NO.  Conversely, ANGII activation 99 
of the ANGII type 1 receptor (AT1R) results in the expression of CAPON and PIN, 100 
whereby the CAPON competes with PSD95 for the binding of nNOS while PIN 101 
destabilises nNOS homodimers (Sharma et al., 2011; Sharma et al., 2013).  102 
Maintaining the balancing of excitatory and inhibitory influences on preautonomic 103 
neurons for normal control shows that ANGII binding to AT1R potentiates neuronal 104 
excitability but this effect is then modulated by the NO-GABAergic feedback system 105 
(Li et al., 2003).  However, in HF, the actions of ANGII are upregulated thereby 106 
allowing PIN to interfere with the production of NO and remove the tonic inhibition 107 
of the preautonomic neuron (Figure 2). 108 
The normal catalytic activity of nNOS requires homodimerisation with the cofactor 109 
endothelial tetrahydrobiopterin (BH4) binding to stabilise the dimer.  This 110 
configuration allows electrons to transfer from the oxygenase domain of one 111 
monomer to the reductase domain of another monomer.  Neuronal NOS activation 112 
without proper BH4 binding uncouples normal electron transfer to produce 113 
superoxide (Alkaitis & Crabtree, 2012; Figure 3).  The availability of BH4 in HF is 114 
known to be impaired in the endothelium of these animals, however it remains to be 115 
seen if a similar reduction in BH4 availability is a characteristic of the central nuclei 116 
involved in cardiovascular regulation (Schmidt & Alp, 2007). 117 
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2.1  Inflammation and reactive oxygen species 118 
While transcriptional, translational and posttranslational mechanisms in the 119 
signalling pathway for nNOS control are evident in cardiovascular pathologies, the 120 
question remains what is/are the trigger(s) for the decoupled control?  These effects 121 
are probably related to increased “oxidant stress” linked to increased reactive 122 
oxygen species (ROS) and pro-inflammatory molecule production.  The generation of 123 
ROS is a normal by-product of cellular metabolism and is tightly regulated by 124 
antioxidant enzymes (Zimmerman & Davisson, 2004).  Pro-inflammatory cytokines 125 
(PICs) increase in the brain, heart and plasma within minutes of a myocardial 126 
infarction (MI).  Some are transported into the hypothalamus and brainstem via the 127 
circumventricular organs, however the appearance of PICs in the brain after MI is 128 
independent of blood-borne cytokines and it has been shown that cardiac 129 
sympathetic afferents activated by myocardial ischaemia signal the brain to increase 130 
cytokine production (Francis et al., 2004).  In the latter study increases in tumor 131 
necrosis factor (TNF)-α and interleukin (IL)-1β were confined to the hypothalamus 132 
suggesting it was not a generalized central response to myocardial injury.  Given the 133 
importance of the hypothalamus in volume regulation, stress responses and 134 
sympathetic drive it is likely that this signal to the brain has a specific function.  135 
Initially it may be protective, but damaging in the longer term.  In the PVN activation 136 
of the membrane-bound enzyme complex NADPH oxidase (Nox) is a major source of 137 
ROS.  In HF, Nox appears to be of some importance as Nox4 (the major isoform 138 
expressed in the PVN) is associated with sympatho-excitation and impaired cardiac 139 
function (Guggilam et al., 2011; Infanger et al., 2010).  140 
 7 
Elevated TNF in the PVN and ventrolateral medulla alters the production of 141 
superoxide and NO leading to sympatho-excitation and fluid imbalance in HF mice 142 
(Guggilam et al., 2011).  In addition, blockade/deletion of TNF in the PVN and 143 
ventrolateral medulla attenuated neurohormonal excitation elicited by HF.  In TNF-α 144 
- knockout mice, or wild type mice where TNF was pharmacologically blocked, there 145 
was a reduction in the production of PICs and ROS.  The HF-induced reduction of 146 
nNOS in these key regulatory sites was decreased, thereby preserving NO levels and 147 
curtailing neurohormonal excitation.  Maintaining NO levels also reduced the 148 
formation of potentially damaging peroxynitrite.  Therefore, TNF and nNOS could 149 
well trigger decoupled control. 150 
Angiotensin II could also be involved as ANGII infusion induces imbalances between 151 
excitatory and inhibitory neurotransmitters and pro- and anti-inflammatory 152 
cytokines in the PVN (Kang et al.,2014).  Paraventriuclar hypothalamic inhibition of 153 
ANGII with the ANGII converting enzyme inhibitor enalaprilat restores the 154 
neurotransmitters and cytokines in the PVN and reduces ANG II- induced 155 
hypertension and cardiac hypertrophy.  In addition, blockade of NF-κB by a number 156 
of different strategies can all diminish the production of superoxide and 157 
peroxynitrite within the PVN in response to systemic ANGII infusion (Kang et al., 158 
2009; Cardinale et al., 2012).  The NF-κB activation sites may be localised to the 159 
proopiomelanocortin or POMC neurons which project to the PVN (Purkayastha et al., 160 
2011). 161 
 162 
 163 
 164 
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2.2 Other mediators 165 
A recent study explored factors regulating the expression of the chemokine SDF-1 166 
(stromal cell-derived factor-1) in the PVN and the mechanisms leading to its 167 
sympatho-excitatory effects (Wei et al., 2014).  This novel cytokine and its receptors 168 
have been found expressed by neurons and glial cells in cardiovascular autonomic 169 
regions of the brain, including the PVN.  Both TNF-α and ANGII were identified as 170 
drivers of SDF-1 expression in PVN and their cardiovascular and sympathetic effects 171 
depended upon SDF-1-mediated activation of the p44/42 MAPK signalling pathway.  172 
Previous work indicates a role for SDF-1 as a mediator of neurohumoral excitation in 173 
HF rats (Wei et al., 2012).  How MAPK signalling leads to sympatho-excitation is not 174 
known.  Phosphorylated MAPKs have nuclear and cytoplasmic effects (Turjanski et 175 
al., 2007) and may have both long- and short-term effects on the excitability of PVN 176 
neurons.  They act on nuclear transcription factors including NF-κB (known to drive 177 
the transcription of a range of inflammatory mediators) and they may augment the 178 
production of pro-hypertensive renin angiotensin system components. 179 
Interestingly, MAPK signalling may also modulate the transient outward potassium 180 
current that normally restrains neuronal excitability in cardiovascular related central 181 
nuclei (Gao et al., 2010).  The delay in neuronal excitation following 182 
hyperpolarization induced by GABA is largely determined by the expression of the 183 
potassium channel subunits Kv4.2 and Kv4.3, however whether this is the case in the 184 
PVN remains to be tested. 185 
Another interesting component to the inflammation-oxidative stress mechanism is 186 
the role of Toll- like receptors (TLRs) in particular TLR4.  Toll-like receptor 4 is a 187 
signalling receptor involved in the innate immune response (Takeda & Akira, 2001).  188 
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Of the 13 TLRs identified in mammals, TLR4 has been implicated in cardiovascular 189 
disease (Baumgarten et al., 2001).  The TLR recognises specific damage associated 190 
molecular patterns (DAMP) with high mobility group box -1 (HMGB1) being the most 191 
important DAMP implicated in various inflammatory conditions.  The TLR4 receptor 192 
is expressed in microglial cells, the immune cell of the brain.  Microglial activation is 193 
related to injury and infection, which results in the release of PICs and ROS and 194 
importantly ANGII stimulation appears to facilitate the inflammatory response in the 195 
PVN (Shi et al., 2010).  Biancardi and colleagues using mice (Biancardi et al., 2016) 196 
have demonstrated a functional interaction between AT1R and TLR4 in mediating 197 
ANGII-dependent microglial activation and oxidative stress within the PVN.  Similarly, 198 
Dange et al., (2014) recently demonstrated that ANGII-infused hypertensive rats had 199 
increased TLR4 expression in the PVN and central blockade of these receptors 200 
delayed the progression of hypertension.  These authors provided evidence that 201 
TLR4 inhibition attenuated ANGII-induced hypertension by down-regulation of 202 
myocardial PICs and reducing circulating levels of plasma noradrenaline indicative of 203 
a reduction in sympathetic activation.  They also showed that activation of TLR4 204 
could induce the sympatho-excitation observed in hypertension, possibly due to 205 
increased PICs.  The same group has recently reported that TLR4 blockade is similarly 206 
protective in the spontaneously hypertensive rat (SHR), a model of human essential 207 
hypertension (Dange et al., 2015).  The SHR animals had increased levels of TLR4 in 208 
the PVN localised to neurons and microglia.  Blockade of TLR4 within the PVN 209 
attenuated both the increase in blood pressure and cardiac hypertrophy in the SHR.  210 
In addition, TLR4 inhibition in the PVN reduced pro-inflammatory cytokines, iNOS, 211 
and transcription factor NF-κB activity within the PVN itself, whereas levels of the 212 
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anti-inflammatory cytokine IL-10 in the PVN were increased.  The damage associated 213 
molecular pattern, HMGB1 may be a mediator of the changes seen in hypertensive 214 
animals, since there was an increase in HMGB1 levels both in the PVN and in the 215 
plasma.  Thus to understand pathological sympatho-excitation, inflammation and 216 
oxidative stress effects need to be investigated further. 217 
 218 
3.  Cardiac vagal afferents 219 
The previous section has described knowledge of triggering factors that impact on 220 
the excitability of PVN-presympathetic neurons and how these might be involved in 221 
cardiac pathologies.  However, where we lack detail is the afferent input to the brain 222 
from sensory mechanisms in the periphery.  Relatively little progress regarding 223 
structure, function and location of these inputs has occurred since cardiac reflexes 224 
were extensively reviewed by Hainsworth 25 years ago (Hainsworth, 1991).  It is 225 
important to again focus attention on cardiac afferents because we have since 226 
learned that resetting of the gain of atrial volume receptors, making them less 227 
sensitive to local signals, occurs in various strains of hypertensive rats as well as in a 228 
sheep model of heart failure.  Also in pregnancy there is a reduction in the sensitivity 229 
of these receptors (Hines et al., 2005; Ricksten et al., 1979; May et al., 2013). 230 
While cardiovascular pathologies might indicate an involvement of the afferent arm, 231 
to date, much is still unknown regarding its normal mode of functioning let alone its 232 
possible contribution to heart disease.  The volume receptors are particularly 233 
challenging, their location making them less accessible than other receptors.  Studies 234 
from as far back as the 1950’s described the electrophysiological properties of 235 
receptors at the veno-atrial junction that were sensitive to volume changes (Paintal, 236 
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1953).  Their morphology was examined initially using classic neuronal stains 237 
(Woollard, 1926; Coleridge et al., 1957; Holmes, 1957) and later electron microscopy 238 
(Tranumjensen, 1975).  However until recently, information on their exact location 239 
and distribution has been lacking; as has any understanding of the molecular 240 
machinery underpinning their function.  Neuroanatomical studies combined with 241 
powerful new imaging techniques are now providing a means to visualize these 242 
receptors.  Furthermore, understanding of the proteins and processes involved in 243 
detecting mechanical stimuli in mammalian systems is now making progress. 244 
There is still greater uncertainty about vagal afferents arising from the ventricles, 245 
despite numerous electrophysiological studies (Hainsworth 1991).  In particular, the 246 
physiological stimuli to which these receptors respond remains to be determined as 247 
it is technically very difficult to isolate responses that arise exclusively from 248 
activation of ventricular vagal afferents.  It may be that the atrial and ventricle 249 
afferents are both chemo- and mechanosensitive.  For these reasons and because 250 
the research of our own group focuses on volume sensing in the veno-atrial junction, 251 
ventricular vagal afferents are not included here.  Nevertheless current thinking on 252 
the molecules and proteins involved in mechanotransduction is likely to apply to 253 
afferents arising from both. 254 
 255 
3.1  Distribution and structure 256 
The sensory atrial volume receptors are said to be in the subendocardial tissue 257 
mainly at the junction of the veins with the atria and in the appendages (Nonidez, 258 
1937; Coleridge et al., 1957; Coleridge et al., 1964; Floyd et al., 1972).  Despite a 259 
number of detailed histological studies of nerves in the endocardium of several 260 
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mammalian species the structure of the AVRs has not been unequivocally 261 
determined (Hainsworth, 1991).  Nonetheless, two structures have been described, 262 
complex unencapsulated endings and end nets.  Myelinated nerves supply complex 263 
unencapsulated endings and there is evidence that these are mechanoreceptors 264 
(Holmes, 1957; Coleridge et al., 1973; Tranumjensen, 1975).  End nets consist of a 265 
fine network of fibres that cover the entire endocardial surface of the heart, 266 
including the ventricular endocardium (Woollard, 1926). 267 
There are few publications where more recent imaging techniques have been 268 
employed.  A confocal and fluorescence microscopy study of the human heart found 269 
no evidence for an end net but did describe myelinated fibres of two types in the 270 
atrial endocardium (Marron et al., 1995).  The fibres were distinguished by the size 271 
of the area covered by their terminals, one type giving rise to terminals over an area 272 
roughly three times that of the other type.  The fibres were mostly tyrosine 273 
hydroxylase or neuropeptide Y positive, traditionally considered as efferents; 274 
however there is evidence that primary sensory neurons may express these markers 275 
(Katz, 1987; Czyzyk-Krzeska, 1991; Finley, 1992). 276 
Another study in the rat using anterograde labelling of cell bodies within the nodose 277 
ganglion and confocal microscopy distinguished “flower-spray” and “end-net” 278 
terminals (Cheng et al., 1997).  These authors proposed that the flower-sprays 279 
resemble early descriptions of complex unencapsulated endings.  However, they did 280 
not differentiate between myelinated and non-myelinated fibres and the lack of 281 
clarity concerning the morphology of these receptors remains.  Indeed there may be 282 
important differences between species since unencapsulated endings have not been 283 
described in rats (Kaufman et al., 1981), apart from the “flower-sprays” alluded to 284 
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above (Cheng et al., 1997).  It has also been suggested that the morphological 285 
differences, which appear to exist between unencapsulated endings and end-nets 286 
are quantitative rather than qualitative and that end nets should in fact be 287 
considered as a variation within the group of unencapsulated endings (Hainsworth et 288 
al., 1991).  Comprehensive studies of this sort describing in detail the morphology 289 
and location of these endings is essential to extending our understanding of how 290 
they operate. 291 
Cheng and colleagues (Cheng et al., 1997) showed for the first time vagal afferent 292 
nerve endings with dense pericellular varicose terminals around small intensely 293 
fluorescent (SIF) cells in each ganglion of the cardiac plexuses as well as retrogradely 294 
labelled neurons in the ganglia.  These observations lend support for the presence of 295 
SIF cells within the intrinsic plexuses of the heart together contributing via a 296 
selection of neurochemical modulators to both local regulation and more 297 
widespread effects (Eranko & Eranko, 1977).  Polymorphic endings contacting both 298 
cardiomyocytes and connective tissue in the endocardium, which could account for 299 
some of the intermediate AB-type discharges (see section 3.2 Function) noted in 300 
electrophysiological studies have also been reported (Cheng et al., 1997).  More 301 
recently vagal intramuscular array afferents in gastrointestinal smooth muscle have 302 
been shown to contact interstitial cells of Cajal (Powley and Phillips, 2011).  303 
Moreover, axons positive for various efferent and afferent markers (tyrosine 304 
hydroxylase, vesicular acetylcholine transporter, nitric oxide synthase and calcitonin 305 
gene-related peptide) meet in the intramuscular array- interstitial cells of Cajal 306 
complexes in the gastrointestinal wall.  This architecture is likely to be integral to the 307 
way these mechanoreceptors work and similar arrangements can be expected for 308 
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cardiac vagal afferents.  With this in mind it will be important to precisely locate 309 
vagal afferents in situ and determine their relationship with neighbouring cells of all 310 
types.  Interestingly a new type of interstitial cell has been described in the heart 311 
(Popescu and Faussone-Pellegrini, 2010).  Initially these cells were called interstitial 312 
cells of Cajal -like cells, but more recently they have been given the name telocytes.  313 
However, though they may be a type of fibrocyte/fibroblast rather than a completely 314 
novel cell type, there is evidence that they are indeed distinct (Bei et al., 2015).  They 315 
are distinguished by the presence of caveolae and extremely long, thin cell body 316 
extensions termed telopods, which can only be visualised using electron microscopy 317 
or specialised light microscopy on ultra-thin tissue sections.  They are present in 318 
myocardial sleeves of human pulmonary veins and all three layers of the cardiac wall, 319 
often in close association with capillaries and nerves (Gherghiceanu et al., 2008).  320 
They may play a role in chemo-mechanical transduction, though this remains to be 321 
determined.  Interestingly they have also been shown in the capsule surrounding 322 
muscle spindles where they could have both a passive mechanical involvement as 323 
well as a neurosecretory role (Diaz-Flores et al., 2013). 324 
 325 
3.2  Function 326 
Atrial receptors have been typically classified as either A-type myelinated or B-type 327 
according to their pattern of discharge in relation to the atrial pressure wave (Paintal, 328 
1953).  Broadly, A-type receptors respond to atrial contraction while B-type are 329 
stimulated by atrial filling and are therefore considered to be the volume receptors.  330 
However, intermediate AB-type discharges have also been described, suggesting that 331 
there may be only one type of receptor with the different discharge patterns 332 
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determined by the location of the receptor rather than any real dissimilarity in 333 
structure (Kappagoda et al., 1976).  These early experiments were carried out in cats 334 
and dogs and recordings were from myelinated afferents postulated to arise from 335 
unencapsulated endings.  Two subtypes of unmyelinated atrial C-fibres, high 336 
frequency and low frequency receptors have been described in cats (Coleridge et al., 337 
1973; Thorén, 1977) and rats (Thorén et al., 1979).  Slowly adapting and rapidly 338 
adapting have also been described in the rat and these fibres might correspond to 339 
the end net (Mifflen & Kunze, 1982, 1984).  With these varying discharge 340 
descriptions there is therefore a clear need to be able to reliably identify AVRs so 341 
that the electrophysiological and morphological/molecular characteristics can be 342 
correlated. 343 
 344 
3.3   Molecular Characterisation 345 
The identification of mechanosensitive channels in mammalian systems remains 346 
elusive.  However, two channel protein families in particular are candidates: the 347 
Epithelial Na Channel/Degenerin/Acid Sensing Ion Channel (ENaC/Degenerin /ASIC) 348 
and Transient Receptor Potential (TRP) families (Delmas et al., 2011).  Recent studies 349 
have indicated a role for amiloride-sensitive channels (i.e. likely to be related to the 350 
ENaC/Degenerin/ASIC family) in mechanotransduction in rat muscle spindles (Simon 351 
et al., 2010). Transient Receptor Potential proteins have been implicated in 352 
mechanosensation in heart as well as other tissue (Inoue et al., 2009). 353 
The  subunit of ENaC is expressed in baroreceptor nerve terminals innervating the 354 
aortic arch and carotid sinus in mice (Drummond et al., 1998).  The ASIC1, 2 and 3 355 
ion channels were found in aortic baroreceptor neurons in the nodose ganglia and 356 
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their terminals in the aortic arch (Lu et al., 2009).  This same study showed that 357 
ASIC2 null mice had an impaired baroreceptor reflex and developed hypertension, 358 
lending support to the idea that compromised mechanosensing of blood pressure 359 
could underlie the disturbed autonomic drive seen in heart failure and hypertension.  360 
Lee and colleagues provide evidence for a role of ASIC3 in blood volume control in 361 
mice, such that blood volume expansion-induced urine flow, neural activation, and 362 
atrial natriuretic peptide (ANP) release were reduced in ASIC3 -/- knockout mice 363 
compared with controls (Lee et al., 2011).  They showed ASIC3-IR co-localising with 364 
Calcitonin Gene Related Protein immunoreactivity (CGRP-IR) on nerve terminals in 365 
the veno-atrial junction area.   However, gadolinium (a non-selective blocker of 366 
stretch- activated ion channels) reduced these blood volume expansion effects both 367 
in ASIC3 -/- and ASIC3 +/+ control mice.  Therefore, the gadolinium sensitivity cannot 368 
be exclusively due to blockade of ASIC3.  369 
Broad ranges of stimuli have been found to activate the TRP family of ion channels, 370 
including direct activation by heat, cell swelling or mechanical perturbations (Ramsey 371 
et al., 2006).  The TRP channels are widely expressed in the cardiovascular system 372 
and there is increasing evidence for their importance in heart disease (Inoue et al., 373 
2006; Watanabe et al,. 2008; Inoue et al., 2009, Feetham et al., 2015).  So far focus 374 
has mostly been on their role in the maintenance of myogenic tone, and vascular 375 
injury and remodelling following insult (Stiber et al., 2012).  Few studies have been 376 
undertaken to look for TRP expression in mechanosensory organs and endings 377 
despite the fact that they are considered to be strong candidates as the elusive 378 
mechanosensitive channels in mammals (Delmas et al., 2011).  Nevertheless there 379 
are some pointers: a pressure-induced calcium influx with characteristics compatible 380 
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with TRP sensitive channels has been described in baroreceptor neurons from 381 
nodose ganglia of rats (Sullivan et al., 1997).  The TRPC1 and TRPC3-5 channels are 382 
present not only in the somata of nodose ganglion sensory neurons but also in the 383 
peripheral axons and mechanosensory endings that terminate as mechanosensitive 384 
receptors in the aortic arch of the rat (Glazebrook et al., 2005).  The TRPC1 channel 385 
has been shown to contribute to light-touch sensation and mechanical responses in 386 
low-threshold cutaneous sensory neurons innervating Merkel cells in mice (Garrison 387 
et al., 2012).  The TRPV4 channel is also present in rat Merkel cells where it may play 388 
a dual role both as a mechanotransducer and in neurosecretory granule exocytosis 389 
(Boulais et al., 2009).  Furthermore, TRPV4 has been implicated in mechanosensation 390 
in inner ear hair cells, but this remains to be proven (Mutai and Heller, 2003).  The 391 
TRPV4 selective activator 4α-phorbol 12,13-didecanoate results in dose-dependent 392 
decreases in blood pressure (Gao et al., 2009).  We have recently provided the first 393 
evidence that in rat heart the TRP channels, TRPC1 and TRPV4 are expressed in 394 
sensory endings found in regions of veno-atrial endocardium where AVRs are located 395 
(Fig 4, 5). The TRPC1 and TRPV4-IR co-localises with synaptophysin, a marker of 396 
neuronal synaptic-like vesicles and CGRP a marker for sensory neurons (Shenton and 397 
Pyner, 2014).  Synaptic-like vesicles have commonly been described in 398 
mechanosensory endings of vertebrate and invertebrate animals (Katz, 1966) and 399 
there is evidence that they play a role in regulating their excitability (Bewick et al., 400 
2005). 401 
Interestingly, one area where the role of TRPV4 as a mechanosensitive channel has 402 
been investigated involves osmotic stimuli and autonomic regulation (Benfenati et 403 
al., 2011).  Changes in osmolality have been shown to elicit cellular responses that 404 
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involve TRPV4-mediated elevations of intracellular calcium (Liedtke et al., 2003) with 405 
activation of intermediate (IK)- and small (SK)- conductance calcium-activated 406 
potassium channels (Sonkusare et al., 2012).  The hypothalamus expresses both 407 
TRPV4 (Guler et al., 2012) and SK channels (Gui et al., 2012) and genetic deletion of 408 
TRPV4 channels results in blunted autonomic response to osmotic disturbances 409 
(Liedtke and Friedman, 2003).  With this in mind a recent study has shown that a 410 
hypo-osmotic stimulus hyperpolarises parvocellular neurons of the PVN through a 411 
TRPV4–SK ion channel mechanism (Feetham et al., 2015). 412 
 413 
3.4  Integration with other systems 414 
At its simplest mechanotransduction is the conversion of a physical deflection (the 415 
stimulus) into a neural signal.  Understanding how this is achieved is essential, 416 
however in a whole behaving organism this is only one small component 417 
contributing to cardiovascular control.  The local cellular environment will influence 418 
the transduction process.  Output from AVRs may be subject to the influence of a 419 
range of neuromodulators and neuroendocrine factors (Antunes-Rodrigues et al., 420 
2004).  Atrial natriuretic peptide in particular is likely to play an important role, since 421 
systemic administration of ANP has been show to decrease renal sympathetic nerve 422 
activity (Lovick and Coote 1989; Yusof et al., 2009).  This suggests that ANP may 423 
activate cardiac vagal afferents that inhibit the spinally projecting vasopressin 424 
neurons at their origin in the PVN (Yusof et al., 2009).  There is evidence for sensory 425 
receptors in epicardium as well as endocardium.  In human hearts, Marron et al., 426 
(1995) found terminals on both sides of the atrial appendages and some on the 427 
epicardial surface of the superior caval and pulmonary veins, where they could 428 
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respond to inflation of the lungs.  Endings in the epicardium were often associated 429 
with epicardial mesothelial cells suggesting the possibility that local 430 
neuromodulators secreted by these cells might regulate afferent output. The SIF 431 
cells (Eranko and Eranko 1977) reside within the cardiac ganglia alongside principal 432 
neurons and the SIF cells seem to be innervated by vagal afferents rather than the 433 
principal neurons (Cheng et al., 1997).  The nature and role of SIF cells is not fully 434 
understood, there is speculation that they may be chemosensory and/or 435 
neurosecretory since they contain neurotransmitters and other neuroactive 436 
substances.  In addition they may be a type of interneuron in the intrinsic neural 437 
network of the heart (Pauza et al., 2014).  These observations provide the 438 
anatomical evidence for “accessory cells” being able to contribute to neural 439 
interactions and output, but further studies are needed to more precisely define 440 
their role and mode of action. 441 
 442 
3.5  Role of atrial volume reflex in cardiovascular disease 443 
Improved understanding of how changes in returning blood volume are sensed and 444 
how they influence cardiac output are timely and important.  Resetting of atrial 445 
volume receptors has been demonstrated in the SHR, the threshold pressure in the 446 
left atrium at which renal nerve inhibition was elicited being higher in the 447 
hypertensive animals compared with controls (Ricksten et al., 1979).  Atrial volume 448 
receptors appear to be less sensitive in both hypertension in rats (de Andrade et al., 449 
2008) and in a sheep model of heart failure (May et al., 2013).  May and colleagues 450 
focused on the effects of heart failure on cardiac sympathetic nerve activity.  In 451 
sheep and other species the reduction in renal sympathetic nerve activity in 452 
 20 
response to activation of AVRs is severely impaired in heart failure.  To date there is 453 
less information on the factors contributing to the increase in cardiac sympathetic 454 
nerve activity observed in heart disease.  It has not so far been possible to carry out 455 
equivalent experiments in humans; nevertheless it has been shown that the 456 
sensitivity of the peripheral component of the volume-sensitive cardiopulmonary 457 
reflex is altered in elderly humans compared with younger controls (Salem 1969; 458 
Cleroux et al., 1989).  Although results were contradictory with the first study 459 
showing an enhancement and the later investigation reporting impairment, 460 
important differences in the two studies may account for these apparent 461 
discrepancies (Crystal and Salem 2012).  There is an ongoing debate over whether 462 
fluid re-distribution rather than accumulation is more important in heart failure 463 
(Dunlap and Sobotka 2013), an issue of clinical relevance when deciding whether 464 
heart failure patients are best treated using current decongestion strategies to 465 
reduce total body salt and water.  One avenue to gain insights for this may come 466 
from pregnancy.  Autonomic reflexes are attenuated during pregnancy and 467 
gestational alterations in central sites that regulate the efferent limb of the reflex 468 
have also been reported (Deng & Kaufman, 1995; Heesch & Rogers, 1995; Cork et al., 469 
2016).  Atrial volume receptor discharge is reduced during pregnancy and is 470 
accompanied with an increase in right atrial dimension to accommodate the 471 
increased blood volume without an increase in right atrial pressure (Hines and 472 
Hodgson et al., 2000; Hines et al., 2005).  However, the reduced afferent discharge 473 
does not appear to be related to the atrial dimension-pressure change, which might 474 
argue for a mechanism within signal transduction being a candidate. 475 
 476 
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4.  Conclusion 477 
The control of the reflex circuit regulating cardiovascular homeostasis is complex.  It 478 
is evident the maintenance of the centrally generated tonic sympatho-inhibition is 479 
dependent upon mechanoreceptors sensing cardiovascular status.  However, our 480 
current understanding would indicate that signalling processes are major 481 
contributors to disturbed cardiovascular control in heart failure and hypertension.  482 
The triggers for these are beginning to be revealed and provide some insights.  483 
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Figure 1:  Schematic to show the components of the atrial volume reflex arc. 767 
A. volume receptors in the right atria of the heart communicate via vagal 768 
afferents with the nucleus tractus solitarii (NTS).  The NTS is reciprocally 769 
connected with the paraventricular nucleus of the hypothalamus (PVN).   The 770 
PVN influences sympathetic outflow via connections with the RVLM and 771 
sympathetic preganglionic neurons in the spinal cord.  772 
B. PVN directed NTS axons target at least four neuronal pools that are 773 
associated with cardiovascular control (1) preautonomic neurons (2) 774 
magnocellular neuronal nitric oxide (nNOS)-containing neurons (3) GABAergic 775 
interneurons connected to preautonomic neurons and (4) nNOS-interneurons 776 
bordering the PVN.  (Pyner, 2014 with permission). 777 
Abbreviations 778 
 PaDC  -Parvocelular-dorsal cap 779 
 PaLM -Parvocellular-lateral magnocellular 780 
 PaVP -Parvocellular-medial parvicellular 781 
 PaV -Parvicellular-ventral part 782 
 3V -3rd ventricle 783 
 RVLM -rostral ventrolateral medulla 784 
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Figure 2 786 
Proposed model for the down regulation of nNOS by posttranslational regulation in 787 
the PVN in HF.  In HF, carboxy-terminal PDZ ligand of nNOS (CAPON) and PIN are 788 
overexpressed due to increased ANGII levels and AT1 receptors in the PVN.  789 
Increased CAPON competes with postsynaptic density (PSD)95 for binding to nNOS 790 
and sequesters nNOS therefore decreasing N-methyl-D-aspartic acid receptor 791 
(NMDAR)/PSD95/nNOS complexes.  Binding of PIN to nNOS in HF destabilises nNOS 792 
dimers, which renders nNOS catalytically inactive by interfering with either the 793 
assembly or dimer stability.  Inactive nNOS monomers are susceptible to 794 
ubiquitination and subsequent proteosomal degradation.  This results in decreased 795 
levels of nNOS in the PVN of HF rats.  A decreased level of nNOS reduces NO 796 
production in the PVN during HF causing an increase in sympathetic nerve activity 797 
(SNA). ( Sharma et al., 2013 with permission). 798 
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Figure 3 800 
Coupled nNOS (nNOS homodimer) produces NO, whereas uncoupled nNOS 801 
monomer produces superoxide.   802 
A. nNOS uncoupling occurs during the conversion of nNOS homodimer to nNOS 803 
monomer.  Two nNOS monomers are connected with the aid of Zn2+ 804 
connection (not shown), making the nNOS homodimer.  BH4 strengthens the 805 
Zn2+ connection, maintaining the dimer form.  In coupled NOS, an electron is 806 
transferred to L-arginine (L-Arg) producing NO and L-citrulline (L-Cit). 807 
B. Electron from NADPH is transferred to O2 in the uncoupled nNOS in the 808 
absence of BH4, thereby producing superoxide. 809 
Abbreviations 810 
FMN/FAD  flavin mononucleotide/flavin adenine dinucleotide 811 
NADPH/NADP nicotinamide adenine dinucleotide phosphate (reduced)/ 812 
nicotinamide adenine dinucleotide phosphate 813 
Fe   iron 814 
CaM   calmodulin 815 
BH4   tetrahydrobiopterin 816 
nNOS   neuronal nitric oxide synthase 817 
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Figure 4 819 
 Mechanosensitive ion channels:  Transient Receptor Potential Canonical 1 (TRPC1) 820 
labelling in the endocardium. SYN immunoreactivity (SYN-IR) (short arrows, A) and 821 
TRPC1-IR (long arrows, B) were both evident within the endocardium.  Panel C is the 822 
merge of A and B, TRPC1-IR coincided with SYN-IR labeling on nerve endings 823 
(arrowheads, C).  Panel C’ is a 3-D Opacity image displayed as an isosurface to 824 
demonstrate the concurrence and compartmentalisation of TRPC1 and SYN labeling 825 
(black arrows, C’).  (Shenton & Pyner, 2014 with permission). 826 
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Figure 5 828 
Mechanosensitive ion channels:  Transient Receptor Potential Vanilloid4 (TRPV4) 829 
labelling in endocardium and myocardium.  TRPV4 immunoreactivity (TRPV4-IR) 830 
(long arrows B, E) was widespread in the endocardium (ENDO) and also extended 831 
into the myocardium (MYO).  Nerve endings identified by SYN-IR (short arrows, A) 832 
were co-labelled with anti-TRPV4 (arrowheads, C).  Panel C’ is the isosurface 833 
presentation of a Volocity 3D slice to illustrate the close relationship between TRPV4 834 
and SYN labeling (black arrows, C’ indicate concurrent TRPV4-SYN labelling).  CGRP-IR 835 
was only rarely found in either endocardium or myocardium (short arrows, D).  836 
However, on the occasions when it was present the endings were also TRPV4 837 
positive (arrowhead, F).  Panel F’ is the isosurface presentation of a Volocity 3D slice 838 
to illustrate the presence of CGRP labeling on TRPV4-positive endings (black arrows, 839 
F’ indicate dual labeling).  The isosurface view F’ is again indicative of anti-channel 840 
and sensory nerve labelling occurring in distinct compartments within the same 841 
ending.  (Shenton & Pyner, 2014 with permission). 842 
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